Buspirone

This classification denotes an anxiolytic with the molecular formula C21H31N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TK65WKS8HL, chemically known as 8-azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)- but generally known as buspirone, which bears US NIH Compound Identifier 2477. Buspirone most often comes in base and hydrochloride forms. European Medicines Agency schedules Buspirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05992MIG. The term BUSPIRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules buspirone in its Anatomical Therapeutic Chemical (ATC) Classification. BUSPIRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buspirone under HS 29335995 and SITC 51576. As of Q4 2014, BUSPIRONE remains the US FDA Preferred Term for this commodity. Buspirone bears US NLM identifiers UMLS ID C0006462 and NCI Concept Code C62013. SMILES: O=C1N(C(=O)CC2(CCCC2)C1)CCCCN1CCN(CC1)C1NCCCN1.